NLRP3 and neoplasm: Both M-MDSCs and G-MDSCs from tumor-inoculated Nlrp3-/- mice lost their ability to suppress T-cell activation and proliferation and demonstrated an extensive transcriptomic reprogramming enriched in inflammatory and metabolic pathways.